Pyran Derivatives: Anti-Breast Cancer Activity and Docking Study


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

Four novel pyran derivatives 1–4 are synthesized and characterized by IR, 1H NMR, HRMS, and single crystal X-ray data. Anticancer activity of the compounds is tested against four human breast cancer cells (HCC1937, HCC70, MDA-MB-436, and BT474) by MTT assay. Molecular docking study supports the biological assay data and suggests that compound 2 has a potential as an anticancer agent.

作者简介

H. Han

Inner Mongolia University For The Nationalities

Email: bin_zhang666@126.com
中国, Tongliao, Inner Mongolia Autonomous Region

Z.-F. Zhang

Nursing Department

Email: bin_zhang666@126.com
中国, Tongliao, Inner Mongolia Autonomous Region

J.-F. Zhang

The First Affiliated Hospital of Inner Mongolia University For The Nationalities

Email: bin_zhang666@126.com
中国, Tongliao, Inner Mongolia Autonomous Region

B. Zhang

The First Affiliated Hospital of Inner Mongolia University For The Nationalities

编辑信件的主要联系方式.
Email: bin_zhang666@126.com
中国, Tongliao, Inner Mongolia Autonomous Region


版权所有 © Pleiades Publishing, Ltd., 2018
##common.cookie##